Medula Communications' Amit Akali + Dentsu Tokyo's Masaya Shimizu join One Show Health, Wellness and Pharmaceutical Awards jury

57931751.jpgx3nwq2uk5b5ybskuypd2.jpegThe One Club for Creativity, the world's foremost non-profit organisation celebrating creative excellence in advertising and design, has today announced the jury for its new Health, Wellness & Pharmaceutical discipline for The One Show 2018.

Amit Akali (above left), chief creative officer, Medula Communications / 'What's Your Problem' Brand Solutions, Mumbai, India and Masaya Shimizu (above, right), planning director, Dentsu, Tokyo, Japan have both been selected as jury members.

Entries can be submitted via, deadline for entry is January 31, 2018.
The jury, representing nine countries, will judge work from around the world based on creativity of ideas and quality of execution. They include:

  • Amit Akali, executive creative director, Medula Communications, Mumbai, India
  • Stephanie Berman, partner, chief creative officer, The Bloc, New York, NY, USA
  • Allison Ceraso, managing director, chief creative officer, Havas Life, New York, NY, USA
  • Kathy Delaney, global chief creative officer, PublicisHealth/Saatchi Wellness, New York, NY, USA
  • Todd Henwood, vice president, creative director, GSW Toronto, Toronto, Ontario, Canada
  • Mirko Kaminski, founder, executive creative director, Achtung Kommunication, Hamburg, Germany
  • June Laffey, executive creative director, Australia and Southeast Asia, McCann Health, Sydney, Australia
  • Brett O'Connor, executive creative director, VCCP Health, London, UK
  • Carles Puig, executive creative director, Grey Health, Santiago, Chile
  • Bernardo Romero, senior vice president, group creative director, Area 23, New York, NY, USA
  • Michael Schreiber, executive creative director, DDB Health, New York, NY, USA
  • Ricardo Sciammarella Pereira, executive creative director, Ogilvy, São Paulo, Brazil
  • Masaya Shimizu, planning director, Dentsu, Tokyo, Japan
  • Joan Wildermuth, executive director, chief creative officer, Juice, New York, NY, USA

Addition of the Health Wellness & Pharmaceutical as a separate discipline is a reflection of the unique demands of the those sectors.  Vertical markets within the discipline include Over-the-Counter, Dietary Supplements/Nutraceuticals, OTC Products & Equipment, Prescription/Pharmaceuticals, Health Services, Awareness/Advocacy/Education/Fundraising and Business-to-Business.  

Says Kevin Swanepoel, CEO, The One Club for Creativity: "This new jury consists of esteemed creative professionals from around the world who specialize in this unique field where work often needs to pass both creative and regulatory muster. Health, wellness and pharma continue to be fast-growing segments with their own unique regulatory challenges, and the creative work deserves to be judged by a separate dedicated jury of advertising experts."

He added the quality of creative work in these areas has advanced significantly in recent years. 

Says Swanepoel: "Soon after launching One Show Rx in 2000 as the ad industry's first awards show for pharma, we recognized much of the work was not yet up to One Show Pencil standards and rolled the discipline back into the overall One Show four years later. Today, health wellness and pharma deserve to be a separate discipline again due to the elevated quality of the work."

The One Show judging takes place in March 2018, with finalists announced in April in lead up the The One Show awards ceremonies on May 9 and 11, 2018 during Creative Week in New York.

For more information about The One Show and to enter, please visit

Leave a comment

About Campaign Brief Asia

A blog for advertising creatives in Asia. To pass on news or advertise on the CB Asia blog, or to subscribe to Campaign Brief Asia or Campaign Brief Australia/NZ magazines, or The Work 09 Annual, email: Kim or Michael

Latest jobs

Retrieving latest jobs

House rules for commenting

Here are the ground rules for posting comments on stories: This site is a moderated blog. Comments that are seen to be more abusive than witty and/or constructive will not be posted. Obviously, we do not allow 'hate speech' or comments that are seen as a personal attack, defamatory, degrading or prejudicial to an individual or company. Overly abusive language also adds nothing to any discussion and will not be published. On occasions we will be asking people to contribute work, opinions and views on various topics - you are free to disagree, so long as you observe the above rules and remain constructive.